Reported Jul 14, 2021 · Terminated
Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by:…
Alvogen, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Alvogen, Inc · 44 Whippany Rd Ste 107 · Morristown, NJ · 07960-4558
Is this the product you have?
- Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film
- Distributed byAlvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03
- Lot codes and dates
Lot #: 36924Exp 6/2021
- Amount recalled
- 9,696 cartons
Where it was sold
- Nationwide
Why it was recalled
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Alvogen, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.